Equity

Daré Bioscience announced a $6 million registered direct offering and private placement of warrants. The offering includes 4,379,581 shares at $1.37 each. Warrants, exercisable after stockholder approval, could add up to 8,759,162 shares, posing potential dilution. The transaction is expected to close around August 17, 2026.